Rewcastle G W, Atwell G J, Chambers D, Baguley B C, Denny W A
J Med Chem. 1986 Apr;29(4):472-7. doi: 10.1021/jm00154a008.
A series of monosubstituted derivatives of the new antitumor agent N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide has been prepared, bearing methyl, methoxy, and chloro groups at available acridine positions. The physicochemical properties and antitumor activity of these compounds varied more with the position than with the nature of the substituent groups. The highest levels of both in vitro and in vivo antileukemic activity were shown by 5-substituted derivatives, while 7- and 8-substituted derivatives possessed the highest selectivity toward the HCT-8 human colon carcinoma line compared to the L1210 mouse leukemia line in vitro.
已制备了新型抗肿瘤药物N-[2-(二甲氨基)乙基]-9-氨基吖啶-4-甲酰胺的一系列单取代衍生物,在吖啶的可用位置带有甲基、甲氧基和氯基团。这些化合物的物理化学性质和抗肿瘤活性随取代基位置的变化比随取代基性质的变化更大。5-取代衍生物在体外和体内均表现出最高水平的抗白血病活性,而7-和8-取代衍生物在体外对HCT-8人结肠癌细胞系的选择性高于L1210小鼠白血病细胞系。